• 0 Posts
  • 134 Comments
Joined 11 days ago
cake
Cake day: January 22nd, 2026

help-circle



  • I thought generics were handled relatively similarly in the EU and the US, but apparently the US does grant a bunch of exclusivities, on top of patents.

    However the biggest difference between those health systems still seems to be how providers bargain for lower prices.

    In the US, insurances bargain for rebates. That means that if you buy a drug with insurance the insurance only pays a small percentage of the drug price. They are still allowed to demand copay on the list price. So often the insurance makes a profit in that transaction. But if you try to go around insurance you have to pay the full list price and will pay even more.

    Over here, the universal healthcare providers bargain with the pharma companies to lower the list price. And with a much greater bargaining power to boot.